Drug class in one race

N/A (innate, non-antigen-specific NK-cell cytotoxicity) drugs for Non-Small Cell Lung Cancer

3 tracked N/A (innate, non-antigen-specific NK-cell cytotoxicity) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the N/A (innate, non-antigen-specific NK-cell cytotoxicity) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

← all N/A (innate, non-antigen-specific NK-cell cytotoxicity) drugs